Simple, cheap drug holds cancer treatment promise
Wed. May. 12 2010 9:48 PM ET
An inexpensive drug already in use for other diseases might hold the key to a completely new way of treating cancers -- not by killing off cancer cells, but by simply reprogramming them.
How exciting to read about Canadian research. The drug is called
No drug company holds the patent in dichloroacetate (DCA), as it is an 'orphan drug'.
Totally funded by patient donations, charity groups and government agencies.
Studying only 5 patients, the findings are only 'proof in principle'. Cancer cells are agressive. They are voracious and require a lot of nutritent. They suppress mitochondria, the part of the cell that converts food into energy, and can kill off surrounding cells if they need too much energy. Good news, indeed!
CTV National News: Avis Favaro on the study
Researchers in Alberta have found that the drug DCA is effective in killing brain cancer and cancer stem cells, which are known as 'the mother of all cancer cells.'
CTV Edmonton: Drug may be cancer breakthrough
Conventionally options such as radiation and chemotherapy are used to kill off tumours, but now it may be possible to simply re-program them.